Your browser doesn't support javascript.
loading
The Australian experience with switching to extended half-life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation.
Brennan, Yvonne; Parikh, Sumit; McRae, Simon; Tran, Huyen.
Affiliation
  • Brennan Y; Australian Haemophilia Centre Directors Organisation (AHCDO), Melbourne, Vic., Australia.
  • Parikh S; Department of Haematology, Westmead Hospital, Sydney, NSW, Australia.
  • McRae S; Australian Haemophilia Centre Directors Organisation (AHCDO), Melbourne, Vic., Australia.
  • Tran H; Australian Haemophilia Centre Directors Organisation (AHCDO), Melbourne, Vic., Australia.
Haemophilia ; 26(3): 529-535, 2020 May.
Article in En | MEDLINE | ID: mdl-32243027
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Factor IX / Factor VIII / Immunoglobulin Fc Fragments / Hemophilia A Type of study: Observational_studies Limits: Adult / Child / Child, preschool / Humans Country/Region as subject: Oceania Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Factor IX / Factor VIII / Immunoglobulin Fc Fragments / Hemophilia A Type of study: Observational_studies Limits: Adult / Child / Child, preschool / Humans Country/Region as subject: Oceania Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: Australia Country of publication: United kingdom